中銀香港(02388.HK):將為個人客戶提供跨櫃台股票交易服務作準備
中銀香港(02388.HK)宣布獲批成為首批增設人民幣櫃台證券的香港上市公司之一,認為雙櫃台模式為投資者提供以港幣或人民幣作為交易貨幣的選擇,增加投資靈活性,同時將有助豐富離岸人民幣市場產品體系,是國家規劃下推動內地和香港互聯互通、進一步強化香港全球離岸人民幣業務樞紐功能的一項重大舉措。
該行表示,作為香港唯一的人民幣業務清算行,將繼續積極支持推動香港離岸人民幣業務的創新發展,為推動人民幣國際化進程,及提升香港國際金融中心地位作出貢獻,並將積極優化手機銀行功能設置,以便在雙櫃台模式正式推出之時,為個人客戶提供跨櫃台股票交易服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.